弗拉辛调节脂质代谢以及肠道菌群,以避免NAFLD
Yang Jing1, Dong Huicong2, Guo Xuanchi1
1School of Clinical Medicine, Hebei University of Engineering, Handan, Hebei, China.
Frontiers in pharmacology
|December 29, 2025
概括
弗拉辛是一种天然化合物,通过调节脂质代谢和恢复肠道微生物群平衡,有效治疗非酒精性脂肪性肝病 (NAFLD). 这项研究阐明了fraxin对抗NAFLD进展的治疗机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 微生物组研究 微生物组研究
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一个全球性的健康问题,对公共卫生保健系统造成重大负担.
- 来自Fraxini皮层的化合物fraxin显示出肝脏保护的潜力,但其在NAFLD中的机制尚未完全理解.
研究的目的:
- 研究fraxin在管理NAFLD中的治疗潜力和潜在机制.
- 在NAFLD治疗中确定fraxin影响的关键分子标和途径.
主要方法:
- 网络药理学确定了fraxin对NAFLD的目标.
- 进行了蛋白质-蛋白质相互作用网络,基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 途径分析.
- 一个甲素胆缺乏症 (MCD) 饮食诱导的NAFLD小鼠模型被用于体内验证,包括肝功能测试,生物化学测试,基因/蛋白质表达分析和16SrRNA测序.
主要成果:
- 网络药理学确定了NAFLD中fraxin的34个潜在目标.
- 弗拉辛治疗显著降低了肝脏指数,内脏脂肪和肝损伤 (AST,ALT) 和炎症 (IL-6,TNF-α) 的血清标志物.
- 弗拉辛降低了主要的脂质代谢标 (FAT/CD36) 和调节了肠道微生物群组成,降低了Firmicutes/Bacteroidota的比率.
结论:
- 弗拉辛通过调节脂质代谢和动脉样硬化相关途径来缓解NAFLD.
- 弗拉辛可以恢复肠道微生物群的恒温,减轻饮食引起的失调.
- 弗拉辛通过综合代谢和微生物组调节来证明NAFLD管理的治疗潜力.
更多相关视频
相关概念视频
Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Lipid Digestion
98.5K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.5K
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
609
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
609
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Lipid Catabolism
804
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
804


